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Leptospirosis is a tropical neglected disease that is
highly under-diagnosed and under-reported, mostly
because of a lack of diagnosis capacity. The Institut
Pasteur International Network includes researchers and
physicians that have a recognized expertise in the field
of leptospirosis epidemiology and diagnosis. Taking
advantage of this international and widespread network
of expertise, we currently aim at implementing the diag-
nosis of leptospirosis in institutes, countries or regions
where it was not available. With the financial support of
the Institut Pasteur International Network, biologists
and researchers from French Guyana, Cameroon, Gua-
deloupe (West Indies), Cote d’Ivoire, Cambodia, New
Caledonia and France currently work at implementing
and inter-calibrating leptospirosis diagnosis in their
respective institutes.
Because of very slow and delicate culture of Leptospira
spp., the early diagnosis of leptospirosis increasingly
relies on PCR. Using its own molecular platform and
expertise, each institute implements the PCR or qPCR
method of its choice for the detection of pathogenic
Leptospira spp. Common Leptospira suspensions are
shared to commonly evaluate the sensitivity of the PCR
assays.
The serological reference method uses the Micro
Agglutination Test (MAT), a method that requires con-
tinuous culture of live leptospires and experienced staff
for interpretation. Therefore, commercially available ser-
ological tests (Elisa for the detection of anti-Leptospira
IgM) are used as a first diagnosis approach. The French
National Reference Center then validates the results and
identifies the infecting serogroup using a reference
MAT panel.
These diagnostic tools are then offered to patients hos-
pitalized with predefined leptospirosis-like symptoms, as
a way to (re-) evaluate the contribution of leptospirosis
to non-malarial febrile illnesses in these countries and
regions.
The global architecture and goals of our Lepto-network
will be presented, together with epidemiological research
perspectives using the tools and expertise developed
through this network.
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